[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 1852 Reported in Senate (RS)]

<DOC>





                                                       Calendar No. 201
118th CONGRESS
  1st Session
                                S. 1852

  To amend the Public Health Service Act to reauthorize a sickle cell 
        disease prevention and treatment demonstration program.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              June 7, 2023

Mr. Scott of South Carolina (for himself, Mr. Booker, and Mr. Warnock) 
introduced the following bill; which was read twice and referred to the 
          Committee on Health, Education, Labor, and Pensions

                           September 6, 2023

               Reported by Mr. Sanders, without amendment

_______________________________________________________________________

                                 A BILL


 
  To amend the Public Health Service Act to reauthorize a sickle cell 
        disease prevention and treatment demonstration program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sickle Cell Disease and Other 
Heritable Blood Disorders Research, Surveillance, Prevention, and 
Treatment Act of 2023''.

SEC. 2. SICKLE CELL DISEASE TREATMENT PREVENTION AND TREATMENT.

    (a) In General.--Section 1106(b) of the Public Health Service Act 
(42 U.S.C. 300b-5(b)) is amended--
            (1) in paragraph (1)(A)(iii), by striking ``prevention and 
        treatment of sickle cell disease'' and inserting ``treatment of 
        sickle cell disease and the prevention and treatment of 
        complications of sickle cell disease'';
            (2) in paragraph (2)(D), by striking ``prevention and 
        treatment of sickle cell disease'' and inserting ``treatment of 
        sickle cell disease and the prevention and treatment of 
        complications of sickle cell disease'';
            (3) in paragraph (3)--
                    (A) in subparagraph (A), by striking ``enter into a 
                contract with'' and inserting ``make a grant to, or 
                enter into a contract or cooperative agreement with,''; 
                and
                    (B) in subparagraph (B), in each of clauses (ii) 
                and (iii), by striking ``prevention and treatment of 
                sickle cell disease'' and inserting ``treatment of 
                sickle cell disease and the prevention and treatment of 
                complications of sickle cell disease''; and
            (4) in paragraph (6), by striking ``$4,455,000 for each of 
        fiscal years 2019 through 2023'' and inserting ``$8,205,000 for 
        each of fiscal years 2024 through 2028''.
    (b) Sense of Congress.--It is the sense of Congress that further 
research should be undertaken to expand the understanding of the causes 
of, and to find cures for, heritable blood disorders, including sickle 
cell disease.
                                                       Calendar No. 201

118th CONGRESS

  1st Session

                                S. 1852

_______________________________________________________________________

                                 A BILL

  To amend the Public Health Service Act to reauthorize a sickle cell 
        disease prevention and treatment demonstration program.

_______________________________________________________________________

                           September 6, 2023

                       Reported without amendment